Jacobs Levy Equity Management, Inc Corvus Pharmaceuticals, Inc. Transaction History

Jacobs Levy Equity Management, Inc

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$2.86 - $4.77 $97,148 - $162,027	-33,968 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$3.56 - $4.86 $28,480 - $38,880	-8,000 Reduced 19.06%	33,968 $121,000
Q3 2020 Nov 16, 2020	SELL	$2.6 - $5.37 $95,331 - $196,896	-36,666 Reduced 46.63%	41,968 $168,000
Q2 2020 Aug 17, 2020	BUY	$2.01 - $4.05 $116 - $234	58 Added 0.07%	78,634 $214,000
Q1 2020 May 15, 2020	BUY	$1.74 - $5.98 $4,489 - $15,428	2,580 Added 3.39%	78,576 $166,000
Q4 2019 Feb 14, 2020	BUY	$2.56 - $5.44 $84,426 - $179,405	32,979 Added 76.67%	75,996 $413,000
Q3 2019 Nov 14, 2019	SELL	$3.01 - $6.5 $50,270 - $108,556	-16,701 Reduced 27.97%	43,017 $129,000
Q2 2019 Aug 13, 2019	BUY	$3.3 - $4.58 $197,069 - $273,508	59,718 New	59,718 $223,000
Q1 2019 May 14, 2019	SELL	$3.75 - $4.97 $210,652 - $279,184	-56,174 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$3.29 - $8.94 $40,796 - $110,856	12,400 Added 28.33%	56,174 $206,000
Q3 2018 Nov 14, 2018	BUY	$8.58 - $11.4 $375,580 - $499,023	43,774 New	43,774 $376,000
Q1 2018 May 15, 2018	SELL	$7.48 - $11.53 $104,914 - $161,719	-14,026 Closed	0 $0
Q4 2017 Feb 13, 2018	BUY	$9.3 - $16.93 $130,441 - $237,460	14,026	14,026 $145,000

30.4M

1.06M

84.3K

Ticker CRVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,553,500
Market Cap $223M
Description
Corvus Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology therapies. Its lead product candidate is Mupadolimab (CPI-006), an anti-CD73 monoclonal antibody, which is in Phase Ib/II clinical trial for non-small cell lung cancer and head and neck cancers. The compan...

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.